Table 2. Molecular follow-up of 14... | American Society of Hematology

Table 2.

Molecular follow-up of 14 relapsing patients

UPN	Time from BMT to p210^BCR-ABL	Time from BMT to MC Detection in Whole Blood	Host Myeloid Cell Detection (Increasing %)^*	Host T-Cell Detection	Time from BMT to p190^BCR-ABL	Time from BMT to Cytogenetic Relapse
137	+6	+9	+9 (19%-65%)	+12	+12	+12
154	+62	+68	+68 (35%-80%)	+68	+80	+80
199	+1	+6	+6 (15%-73%)	+6	+10	+11
235^†	+1	+3	+3 (6%-95%)	+7	+4	+6
245^†	+6	+6	+6 (17%-60%)	+12	+10	+12
251^†	+22	+25	+25 (20%-75%)	+34	+24	+30
267^†	+24	+28	+28 (45%-80%)	DC	+24	+30
274^†	+1	+3	+3 (35%-90%)	+3	+3	+5
286	+1	DC	DC	DC	+4	+5
304^†	+3	+4	+4 (50%-78%)	+6	+5	+6
305	+1	+1	+1 (60%-91%)	+1	+4	+5
322	+3	+2	+8 (15%-78%)	+2	+6	+10
2056	+12	+14	+14 (28%-65%)	DC	+18	+24
2072	+1	+1	+1 (25%-70%)	+5	+5	+5

UPN	Time from BMT to p210^BCR-ABL	Time from BMT to MC Detection in Whole Blood	Host Myeloid Cell Detection (Increasing %)^*	Host T-Cell Detection	Time from BMT to p190^BCR-ABL	Time from BMT to Cytogenetic Relapse
137	+6	+9	+9 (19%-65%)	+12	+12	+12
154	+62	+68	+68 (35%-80%)	+68	+80	+80
199	+1	+6	+6 (15%-73%)	+6	+10	+11
235^†	+1	+3	+3 (6%-95%)	+7	+4	+6
245^†	+6	+6	+6 (17%-60%)	+12	+10	+12
251^†	+22	+25	+25 (20%-75%)	+34	+24	+30
267^†	+24	+28	+28 (45%-80%)	DC	+24	+30
274^†	+1	+3	+3 (35%-90%)	+3	+3	+5
286	+1	DC	DC	DC	+4	+5
304^†	+3	+4	+4 (50%-78%)	+6	+5	+6
305	+1	+1	+1 (60%-91%)	+1	+4	+5
322	+3	+2	+8 (15%-78%)	+2	+6	+10
2056	+12	+14	+14 (28%-65%)	DC	+18	+24
2072	+1	+1	+1 (25%-70%)	+5	+5	+5

Time from BMT to detection of molecular parameters and cytogenic relapse is expressed in months post-BMT.

The increasing percentage of host myeloid cells from initial detection to relapse is shown.

Indicates T-cell–depleted patients.